Copyright
©The Author(s) 2025.
World J Hepatol. Jul 27, 2025; 17(7): 106151
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.106151
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.106151
Table 3 Univariate and multivariate Cox proportional hazards regression analyses of overall survival-associated factors in The Cancer Genome Atlas liver hepatocellular carcinoma cohort
Variables | Univariate analysis | Multivariate analysis | ||||
HR | 95%CI | P value | HR | 95%CI | P value | |
Age | 1.609 | 1.040-2.491 | 0.033 | 1.564 | 0.997-2.453 | 0.051 |
Gender | 0.758 | 0.496-1.158 | 0.200 | 0.855 | 0.549-1.332 | 0.488 |
Pathologic stage | 1.134 | 0.749-1.717 | 0.553 | 1.037 | 0.686-1.568 | 0.862 |
Clinical stage | 0.925 | 0.606-1.411 | 0.717 | 0.952 | 0.629-1.441 | 0.815 |
New tumor event after initial treatment | 1.058 | 0.686-1.630 | 0.799 | 1.097 | 0.707-1.704 | 0.679 |
Rac family small GTPase 3 | 2.254 | 1.460-3.480 | < 0.001 | 2.220 | 1.428-3.451 | < 0.001 |
- Citation: Liu R, Li JC, Li SD, Li JD, He RQ, Chen G, Feng ZB, Wei JL. Deciphering the oncogenic role of Rac family small GTPase 3 in hepatocellular carcinoma through multiomics integration. World J Hepatol 2025; 17(7): 106151
- URL: https://www.wjgnet.com/1948-5182/full/v17/i7/106151.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i7.106151